#METABOLOMICS WORKBENCH Arun_Sreekumar_20170519_083902 DATATRACK_ID:915 STUDY_ID:ST000611 ANALYSIS_ID:AN000936 PROJECT_ID:PR000447 VERSION 1 CREATED_ON May 27, 2017, 1:33 pm #PROJECT PR:PROJECT_TITLE Prostate cancer disparity study on urine PR:PROJECT_SUMMARY LC/MS-MS measurement of inosine to adenosine ratio as well as GC/MS measurement PR:PROJECT_SUMMARY of sarcosine relative values in urine samples from PR:INSTITUTE Baylor College of Medicine PR:LAST_NAME Sreekumar PR:FIRST_NAME Arun PR:ADDRESS One Baylor Plaza, Houston, TX, 77030, USA PR:EMAIL Arun.Sreekumar@bcm.edu PR:PHONE 713-798-3305 #STUDY ST:STUDY_TITLE Relative level of inosine/adenosine and sarcosine ST:STUDY_SUMMARY LC/MS-MS measurement of inosine to adenosine ratio as well as GC/MS measurement ST:STUDY_SUMMARY of sarcosine relative values in urine samples from prostate cancer and case ST:STUDY_SUMMARY control patients in a group of ancestry verified African American and European ST:STUDY_SUMMARY American. ST:INSTITUTE Baylor college of medicine ST:LAST_NAME Sreekumar ST:FIRST_NAME Arun ST:ADDRESS One Baylor Plaza, 120D, Houston, TX, 77030 ST:EMAIL Arun.Sreekumar@bcm.edu ST:PHONE 713-798-3305 #SUBJECT SU:SUBJECT_TYPE Human SU:SUBJECT_SPECIES Homo sapiens SU:TAXONOMY_ID 9606 #SUBJECT_SAMPLE_FACTORS: SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Additional sample data SUBJECT_SAMPLE_FACTORS - 17122 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 18175 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 18317 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 18331 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 18850 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 18882 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 18887 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 18901 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 18998 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 19049 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 19270 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 19418 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 19502 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 19675 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 19678 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 19766 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 19805 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 20115 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 20141 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 20149 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 15298 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 16710 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 17234 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 17891 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 17897 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 17985 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 18020 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 18064 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 18073 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 18097 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 18115 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 18177 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 18183 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 18234 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 18296 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 18302 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 18378 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 18414 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 18439 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 18494 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 18515 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 18517 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 18538 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 18567 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 18640 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 18765 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 18893 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 18939 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 18970 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 19064 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 19139 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 19144 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 19192 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 19205 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 19223 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 19236 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 19379 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 19402 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 19428 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 19460 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 19515 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 19580 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 19641 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 19644 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 19666 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 19682 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 19800 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 19815 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 19838 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 19853 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 19901 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 19924 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 20082 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 20120 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 20144 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 20262 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 20405 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 20436 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 20463 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 21042 group:Cancer | RACE:African American SUBJECT_SAMPLE_FACTORS - 17786 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 17879 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 18004 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 18013 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 18014 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 18030 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 18091 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 18098 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 18102 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 18106 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 18112 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 18137 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 18140 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 18156 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 18162 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 18174 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 18415 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 18469 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 18489 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 18628 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 18661 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 18664 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 18665 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 18678 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 18717 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 18783 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 18790 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 19224 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 19303 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 19332 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 19531 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 19622 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 19647 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 19721 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 19843 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 19869 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 19880 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 20049 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 20051 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 20070 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 20078 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 20079 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 20092 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 20099 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 20103 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 20319 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 20323 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 20361 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 20752 group:Case control | RACE:African American SUBJECT_SAMPLE_FACTORS - 17817 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 17848 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 17883 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 17893 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 17902 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 17962 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 18010 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 18035 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 18054 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 18056 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 18062 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 18072 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 18077 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 18154 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 18225 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 18240 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 18250 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 18261 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 18265 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 18277 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 18285 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 18323 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 18328 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 18402 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 18404 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 18450 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 18463 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 18541 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 18551 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 18559 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 18580 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 18618 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 18638 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 18702 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 18796 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 18808 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 18863 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 18868 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 19083 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 19151 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 19152 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 19178 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 19193 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 19214 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 19237 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 19247 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 19255 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 19353 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 19405 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 19464 group:Case control | RACE:European American SUBJECT_SAMPLE_FACTORS - 18228 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 18262 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 18542 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 18613 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 18669 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 18734 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 18742 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 18830 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 18918 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 19022 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 19034 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 19169 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 19189 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 19550 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 19575 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 19648 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 19655 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 19837 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 20013 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 20150 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 20357 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 15862 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 16593 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 17024 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 17585 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 17587 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 17721 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 18018 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 18061 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 18063 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 18083 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 18109 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 18117 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 18130 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 18295 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 18312 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 18488 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 18557 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 18596 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 18609 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 18706 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 18724 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 18737 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 18775 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 18803 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 18811 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 18834 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 18865 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 18876 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 18888 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 18890 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 18900 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 18904 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 18912 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 18944 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 18955 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 18978 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 18988 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 19001 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 19023 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 19025 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 19058 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 19084 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 19093 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 19095 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 19113 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 19129 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 19157 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 19168 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 19243 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 19274 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 19312 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 19834 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 19870 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 20020 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 20036 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 20101 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 20285 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 20406 group:Cancer | RACE:European American SUBJECT_SAMPLE_FACTORS - 20694 group:Cancer | RACE:European American #COLLECTION CO:COLLECTION_SUMMARY Urine from 80 each of ancestry typed AA and EA prostate cancer patients were CO:COLLECTION_SUMMARY used for this analysis. Urine specimens were spun and the supernatant was stored CO:COLLECTION_SUMMARY at −70°C until analysis. #TREATMENT TR:TREATMENT_SUMMARY NA #SAMPLEPREP SP:SAMPLEPREP_SUMMARY 10uL urine supernatant was mixed with 40 uL of an equimolar mixture containing SP:SAMPLEPREP_SUMMARY two standard compounds ([15N] Tryptophan and Zeatine) in an equal volume of SP:SAMPLEPREP_SUMMARY water and methanol prior to LC-MS analysis. #CHROMATOGRAPHY CH:CHROMATOGRAPHY_TYPE Reversed phase CH:INSTRUMENT_NAME Agilent 1290 Infinity CH:COLUMN_NAME Agilent SB-CN RRHD (3.0*100mm*1.8um) #ANALYSIS AN:ANALYSIS_TYPE MS #MS MS:MS_COMMENTS - MS:INSTRUMENT_NAME Agilent MS:INSTRUMENT_TYPE Triple quadrupole MS:MS_TYPE ESI MS:ION_MODE POSITIVE #MS_METABOLITE_DATA MS_METABOLITE_DATA:UNITS uM MS_METABOLITE_DATA_START Samples 17122 18175 18317 18331 18850 18882 18887 18901 18998 19049 19270 19418 19502 19675 19678 19766 19805 20115 20141 20149 15298 16710 17234 17891 17897 17985 18020 18064 18073 18097 18115 18177 18183 18234 18296 18302 18378 18414 18439 18494 18515 18517 18538 18567 18640 18765 18893 18939 18970 19064 19139 19144 19192 19205 19223 19236 19379 19402 19428 19460 19515 19580 19641 19644 19666 19682 19800 19815 19838 19853 19901 19924 20082 20120 20144 20262 20405 20436 20463 21042 17786 17879 18004 18013 18014 18030 18091 18098 18102 18106 18112 18137 18140 18156 18162 18174 18415 18469 18489 18628 18661 18664 18665 18678 18717 18783 18790 19224 19303 19332 19531 19622 19647 19721 19843 19869 19880 20049 20051 20070 20078 20079 20092 20099 20103 20319 20323 20361 20752 17817 17848 17883 17893 17902 17962 18010 18035 18054 18056 18062 18072 18077 18154 18225 18240 18250 18261 18265 18277 18285 18323 18328 18402 18404 18450 18463 18541 18551 18559 18580 18618 18638 18702 18796 18808 18863 18868 19083 19151 19152 19178 19193 19214 19237 19247 19255 19353 19405 19464 18228 18262 18542 18613 18669 18734 18742 18830 18918 19022 19034 19169 19189 19550 19575 19648 19655 19837 20013 20150 20357 15862 16593 17024 17585 17587 17721 18018 18061 18063 18083 18109 18117 18130 18295 18312 18488 18557 18596 18609 18706 18724 18737 18775 18803 18811 18834 18865 18876 18888 18890 18900 18904 18912 18944 18955 18978 18988 19001 19023 19025 19058 19084 19093 19095 19113 19129 19157 19168 19243 19274 19312 19834 19870 20020 20036 20101 20285 20406 20694 Factors group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Cancer | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:African American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Case control | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American group:Cancer | RACE:European American Adenosine 2.67 1.06 1.38 0.88 0.23 1.34 1.46 2.29 1.94 1.77 2.00 0.82 0.38 3.84 0.78 5.03 0.97 0.87 1.30 0.36 4.35 3.30 1.56 0.78 1.49 0.55 2.65 1.88 3.08 2.21 1.31 0.64 1.61 0.37 0.64 0.53 0.93 1.21 0.37 0.26 0.89 0.15 0.30 0.31 0.60 1.10 0.70 0.49 0.47 1.46 0.70 0.18 0.94 1.03 0.65 0.85 0.48 0.26 0.75 0.52 0.79 3.95 5.89 3.82 11.97 1.72 1.35 2.60 0.85 0.42 0.59 0.56 0.76 1.63 0.53 1.18 0.72 0.24 1.98 0.33 2.93 1.40 1.94 2.45 2.10 1.18 1.45 1.01 2.10 1.14 0.71 1.55 1.99 0.54 1.99 1.40 2.43 1.73 1.89 1.08 0.15 0.44 0.63 0.14 0.25 0.21 1.23 0.13 1.13 0.11 1.72 1.31 0.27 1.16 0.41 2.58 0.65 0.57 1.32 3.13 0.64 0.97 1.56 0.61 0.89 0.67 0.67 0.65 0.13 1.71 1.48 2.59 1.87 2.22 1.43 2.67 0.89 1.09 1.19 2.52 1.34 2.66 0.89 1.00 2.26 0.86 0.75 0.79 1.79 0.28 0.78 0.47 0.30 0.16 0.58 0.90 0.24 0.74 0.17 0.22 0.61 0.12 0.11 1.18 0.31 2.02 1.43 1.22 0.74 0.29 0.72 1.83 0.31 0.29 0.21 0.27 0.40 0.13 1.97 0.60 2.04 1.15 1.98 0.67 1.28 0.77 1.31 1.33 0.40 1.36 0.83 0.72 1.85 1.19 1.30 3.35 0.67 0.44 1.40 1.32 1.46 1.17 3.82 3.55 0.85 0.69 1.40 0.74 1.28 2.31 1.64 0.69 0.47 0.94 0.80 0.52 0.45 0.94 1.14 0.47 1.50 0.29 0.34 0.29 0.72 0.71 1.22 0.43 0.35 0.20 0.20 0.09 0.89 0.81 1.47 0.83 0.83 1.04 0.27 0.57 0.50 0.69 0.37 0.48 0.37 0.43 1.57 0.21 0.34 0.43 0.22 0.27 0.34 0.98 0.81 0.36 1.00 1.25 0.43 Inosine 0.13 4.46 1.86 2.81 0.81 0.11 0.07 0.43 4.42 1.21 1.09 1.10 1.19 2.47 3.62 4.91 0.15 0.29 0.34 0.09 6.11 0.29 0.90 0.12 0.13 0.10 0.18 1.08 2.79 0.49 0.90 0.13 2.07 0.08 0.07 0.19 0.29 0.89 0.12 0.05 0.67 0.07 0.26 1.63 0.82 0.95 0.85 0.13 0.19 0.70 0.44 0.14 0.98 0.41 0.93 1.27 0.62 0.02 0.16 0.20 0.78 3.87 3.46 4.93 23.47 0.84 2.62 0.60 0.28 0.76 0.26 0.28 2.61 0.24 0.22 0.51 0.17 0.04 2.74 0.04 0.28 0.09 0.12 0.00 0.50 0.25 0.11 0.53 1.78 0.22 0.52 0.52 1.06 0.42 1.74 1.34 3.73 0.54 0.70 0.46 0.47 0.06 0.09 0.09 0.14 0.03 0.84 0.06 0.00 0.07 0.00 1.66 0.12 0.19 0.11 1.76 0.10 0.12 0.43 4.02 0.17 0.49 0.44 0.35 0.26 0.71 0.21 0.28 0.08 0.16 0.08 0.16 0.43 0.00 0.13 0.39 0.41 0.29 0.77 0.16 0.40 0.38 1.27 0.53 1.04 0.36 0.43 3.46 1.10 0.24 0.22 0.21 0.12 0.10 0.21 0.19 0.30 0.37 0.11 0.41 0.21 0.00 0.08 0.72 0.10 0.79 0.67 1.64 0.38 0.21 0.34 0.62 0.17 0.06 0.06 0.15 0.05 0.00 0.55 1.34 2.01 0.71 1.60 0.07 0.41 0.74 0.19 1.17 0.14 0.56 1.83 0.27 1.49 0.79 0.49 3.10 1.48 0.18 1.08 0.30 0.15 1.10 0.52 0.29 1.22 0.54 0.71 0.21 0.15 0.35 2.25 0.62 0.09 0.31 0.86 0.21 0.20 0.40 2.85 0.02 1.04 0.05 0.14 0.12 0.32 0.14 0.67 0.24 0.06 0.38 0.06 0.07 1.11 0.15 0.16 0.93 0.26 0.36 0.10 0.77 1.39 0.13 0.00 0.05 0.11 0.17 0.42 0.06 0.25 0.10 0.17 0.20 0.07 0.48 0.21 0.18 0.59 0.58 0.08 MS_METABOLITE_DATA_END #METABOLITES METABOLITES_START metabolite_name Kegg ID PubChem quantitated m/z Retention time Adenosine C00212 3512 268/136 2.6 Inosine C00294 3588 269/137 3 METABOLITES_END #END